NEUP 8-K 2026-01-07

Neuphoria Therapeutics Inc. (NEUP) 8-K dated 2026-01-07 — accession 0001213900-26-002245. This URL is the filing, not the NEUP hub.

Neuphoria Therapeutics Inc. (NEUP) is a biotechnology company listed on NASDAQ.

Neuphoria Therapeutics Inc. filed a 8-K on 2026-01-07. Accession 0001213900-26-002245.

Cached items: 1.01, 1.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.

Not investment advice. The NEUP SEC hub lists recent forms. The stock page is the research view.